Summary
This prediction ended on 03.11.22 with a price of €46.20. The price of Roku decreased from the start of the prediction. Compared to the start price this resulted in a performance of -17.36%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Roku | -1.100% | -1.100% | 72.650% | 87.930% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % | 64,25 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % | 84,97 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % | 79,25 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % | 68,08 % |
According to BiotechBee what are the pros and cons of Roku for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Roku diskutieren
Sell mit Kursziel 43,0